Related Articles for PubMed (Select 18312665)

Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy.

Hobson AR, Petley G, Morton G, Dawkins KD, Curzen NP.

Thromb J. 2008 Feb 29;6:1.

PMID: 18312665 [PubMed - in process]

Related Articles Free article in PMC

The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis.

Blindt R, Stellbrink K, de Taeye A, Müller R, Kiefer P, Yagmur E, Weber C, Kelm M, Hoffmann R.

Thromb Haemost. 2007 Dec;98(6):1329-34.

PMID: 18064332 [PubMed - indexed for MEDLINE]

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.

Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D.

J Am Coll Cardiol. 2007 Jun 19;49(24):2312-7. Epub 2007 Jun 4.

PMID: 17572245 [PubMed - indexed for MEDLINE]

Stent thrombosis is associated with an impaired response to antiplatelet therapy.

Wenaweser P, Dörffler-Melly J, Imboden K, Windecker S, Togni M, Meier B, Haeberli A, Hess OM.

J Am Coll Cardiol. 2005 Jun 7;45(11):1748-52.

PMID: 15936599 [PubMed - indexed for MEDLINE]

Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.

Carlsson J, von Wagenheim B, Linder R, Anwari TM, Qvist J, Petersson I, Magounakis T, Lagerqvist B.

Clin Res Cardiol. 2007 Feb;96(2):86-93. Epub 2006 Dec 22. Review.

PMID: 17180577 [PubMed - indexed for MEDLINE]

The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation.

Shim CY, Yoon SJ, Park S, Kim JS, Choi JR, Ko YG, Choi D, Ha JW, Jang Y, Chung N, Shim WH, Cho SY.

Int J Cardiol. 2008 Jun 23. [Epub ahead of print]

PMID: 18579227 [PubMed - as supplied by publisher]

Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.

Buch AN, Singh S, Roy P, Javaid A, Smith KA, George CE, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R.

Am J Cardiol. 2007 Jun 1;99(11):1518-22. Epub 2007 Apr 13.

PMID: 17531573 [PubMed - indexed for MEDLINE]

Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.

Zimarino M, Renda G, De Caterina R.

Drugs. 2005;65(6):725-32. Review.

PMID: 15819586 [PubMed - indexed for MEDLINE]

[The effects of post coronary stenting triple antiplatelet therapies on platelet functions]

Han YL, Su QF, Li Y, Kang J, Yan CH, Wang SL.

Zhonghua Nei Ke Za Zhi. 2006 Aug;45(8):635-8. Chinese.

PMID: 17074146 [PubMed - indexed for MEDLINE]

10:

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.

Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, Serebruany V.

Thromb Res. 2007;119(3):277-84. Epub 2006 Mar 24.

PMID: 16563469 [PubMed - indexed for MEDLINE]

11:

Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.

Wenaweser P, Windecker S, Billinger M, Cook S, Togni M, Meier B, Haeberli A, Hess OM.

Am J Cardiol. 2007 Feb 1;99(3):353-6. Epub 2006 Dec 14.

PMID: 17261397 [PubMed - indexed for MEDLINE]

12:

Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial).

Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Hong MK, Kim HS, Ko JK, Park JH, Lee JH, Choi SW, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Park SJ; DECLARE-Long Study Investigators.

Am J Cardiol. 2007 Oct 1;100(7):1103-8. Epub 2007 Jul 18.

PMID: 17884371 [PubMed - indexed for MEDLINE]

13:

Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.

Gurbel PA, DiChiara J, Tantry US.

Am J Cardiol. 2007 Oct 22;100(8B):18M-25M. Review.

PMID: 17950828 [PubMed - indexed for MEDLINE]

14:

Stent thrombosis following drug-eluting stent implantation. A single-center experience.

Vaknin-Assa H, Assali A, Ukabi S, Lev EI, Kornowski R.

Cardiovasc Revasc Med. 2007 Oct-Dec;8(4):243-7.

PMID: 18053945 [PubMed - indexed for MEDLINE]

15:

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation.

JAMA. 2002 Nov 20;288(19):2411-20. Erratum in: JAMA. 2003 Feb 26;289(8):987..

PMID: 12435254 [PubMed - indexed for MEDLINE]

16:

A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography.

Hobson AR, Petley GW, Dawkins KD, Curzen N.

Platelets. 2007 Nov;18(7):497-505.

PMID: 17957565 [PubMed - indexed for MEDLINE]

17:

[Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?]

Baer FM, Erdmann E.

Dtsch Med Wochenschr. 2007 Jun 8;132(23):1275-80. Review. German.

PMID: 17541871 [PubMed - indexed for MEDLINE]